Independence Bank of Kentucky’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
IA
VCM
VAM
Independence Bank of Kentucky's AZN Position: Q1 2026 in Review
Independence Bank of Kentucky sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 780 shares — an estimated $143K sold.
Independence Bank of Kentucky first reported a position in AZN in Q3 2019 and held it in 26 quarters. The position peaked at $143K in Q4 2025. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Independence Bank of Kentucky reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
- Independence Bank of Kentucky sold 780 AstraZeneca shares in Q1 2026, an estimated $143K.
- Independence Bank of Kentucky first reported a position in AstraZeneca in Q3 2019 and held it in 26 quarters.
- Independence Bank of Kentucky's AstraZeneca position peaked at $143K in Q4 2025.
- 1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Independence Bank of Kentucky's 13F filing for Q1 2026, filed 30 Apr 2026.